相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells
Thomas W. Grunt et al.
FRONTIERS IN ONCOLOGY (2021)
Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity
Sana Kouba et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Renata Zajaczkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Progress in research on paclitaxel and tumor immunotherapy
Linyan Zhu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer
James W. Opzoomer et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
Joel Guigay et al.
FRONTIERS IN ONCOLOGY (2019)
A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients
Takanori Watanabe et al.
PLOS ONE (2019)
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up A Phase 1b Clinical Trial
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Deepali Waghray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma
Mahdi Zargar et al.
ONCOLOGIST (2018)
Overexpression of low density lipoprotein receptor-related protein 1 (LRP1) is associated with worsened prognosis and decreased cancer immunity in clear-cell renal cell carcinoma
Chenchen Feng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Different Nanoformulations Alter the Tissue Distribution of Paclitaxel, Which Aligns with Reported Distinct Efficacy and Safety Profiles
Feng Li et al.
MOLECULAR PHARMACEUTICS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Vivek Verma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Oxidative stress-induced DNA damage and homocysteine accumulation may be involved in ovarian cancer progression in both young and old patients
Shazia Anwer Bukhari et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2016)
Chemotherapy is getting 'smarter'
Thomas Mehrling
FUTURE ONCOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Identification of P-Glycoprotein and Transport Mechanism of Paclitaxel in Syncytiotrophoblast Cells
Na-Young Lee et al.
BIOMOLECULES & THERAPEUTICS (2014)
Combination of Dendrimer-Nanovector-Mediated Small Interfering RNA Delivery to Target Akt with the Clinical Anticancer Drug Paclitaxel for Effective and Potent Anticancer Activity in Treating Ovarian Cancer
Shashwati Kala et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs
Gamaleldin I. Harisa et al.
SAUDI PHARMACEUTICAL JOURNAL (2014)
HIGHLY EFFICIENT CONDENSATION OF GLYCEROL TO CYCLIC ACETALS CATALYZED BY TITANIUM-EXCHANGED MONTMORILLONITE
Takato Mitsudome et al.
HETEROCYCLES (2012)
Long-term toxic effects of adjuvant chemotherapy in breast cancer
H. A. Azim et al.
ANNALS OF ONCOLOGY (2011)
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines
Ana Podolski-Renic et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hypocholesterolemia, an unfavorable feature of prognostic value in chronic myeloid leukemia
Claude P. Muller et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer
Hakan Camuzcuoglu et al.
GYNECOLOGIC ONCOLOGY (2009)
Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in cremophor (Taxol)
A Sparreboom et al.
CLINICAL CANCER RESEARCH (2005)
Low-density lipoprotein reconstituted by pyropheophorbide cholesteryl oleate as target-specific photosensitizer
G Zheng et al.
BIOCONJUGATE CHEMISTRY (2002)
分享论文
